For Investors & Partners

The Next Major Financial
Category in Healthcare.

Healthcare is a $4.5 trillion market in the United States alone. The employer sponsored segment, where cost responsibility sits, has never had a forecasting layer. Metra is building that layer. What comes next is a category, not a product.

Why This Is a Category, Not a Product

๐Ÿ—๏ธ

Category Creator

Metabolic Intelligence and Forecasting does not yet exist as a recognized category. Metra is defining it, naming it, and building the infrastructure it runs on. First mover advantage in category creation is the most durable competitive moat in enterprise software.

๐Ÿ’ฐ

Multi Billion Dollar Opportunity

United States employers collectively spend more than $1 trillion on employee health benefits annually (Kaiser Family Foundation, 2023). Even a modest reduction in preventable, metabolically driven claims represents tens of billions in recoverable cost. One of the largest under addressed financial leverage points in enterprise budgets.

๐Ÿ”Œ

Financial Infrastructure Layer

Metra is not a wellness app with a B2B sales motion. It is a data layer that sits between continuous workforce behavior and employer healthcare cost, generating the signals that make prediction possible and intervention actionable. Infrastructure scales differently than applications.

๐Ÿ“ก

Structural Network Effects

Individual adoption creates enterprise pipeline. Enterprise adoption generates population level data. Population data improves the prediction model. The model improvement drives engagement. The flywheel is structural, not manufactured.

The Quote We Lead With

There will come a time when business leaders look back and ask how companies operated without forecasting their healthcare cost. The answer will be that they did not have the tools. Now they do. The companies that move first will hold a structural cost advantage that compounds annually. The companies that wait will keep explaining variance.

What Closing the Round Funds

The platform is in market with enterprise pilots and a published actuarial methodology. The current investment round is sized to expand the deployment team that supports enterprise rollouts, extend the metabolic signal model into the broader metabolic syndrome cluster including the coronary heart disease tail, build the partnership tooling that supports broker and consultant deployments at scale, and deepen the privacy and security posture that the enterprise governance buyer requires. The use of funds is structured against measurable category creation milestones rather than vanity growth metrics.

Investor and Media Inquiries

The leadership team is available for investor diligence, media inquiries, and partnership conversations. A thirty minute briefing is the right first step. All inquiries are routed through care@usemetra.com.

Request an Investor or Media Briefing.

Investor diligence, partnership conversations, and media inquiries are routed through a single inbox. A thirty minute briefing covers the category thesis, the platform architecture, the actuarial methodology, and the structural network effects driving the flywheel.

โœ‰ Request an Investor or Media Briefing โ†“ Download the Actuarial Brief โ—† Read the Intelligence Series